Claudine Vermot-Desroches

Claudine Vermot-Desroches is Research Director Immuno-Oncology of Domain Therapeutics. She joined the company in 2021 to coordinate and contribute to defining the strategic orientation of the immune-oncology pipeline of the company. Formerly, Claudine has over 25 years of experience in the field of immunotherapies. She masters translational medicine value chain covering target validation, therapeutic mAb generation, industrial bioprocesses, and team management with a track record of 4 drug candidates out-licensed to international pharmaceutical companies. Most recently, she was acting at TheraWings consulting focused on translational expertise in human life science and biotechnology. She was successively Scientific Director at Diaclone, OPI EUSA Pharma, and at iDD biotech (co-founder and board member also). Claudine has a Ph.D. in Immunology from the University of Lyon (France) with a fellowship from the University of Helsinki (Finland).